clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Global Research Program Launched to Deploy Blood Biomarker Testing of Alzheimer’s…
News & Features
Anti-Malarial Compound Shows Promise for Treating Polycystic Ovary Syndrome
News & Features
AI-Powered Liquid Biopsy Delivers Ultrasensitive Cancer Detection
Informatics
Killer Phage-Like Tails in Bacteria May Crack Microbial Drug Resistance
News & Features
AI Outperforms Radiologists in Detecting Prostate Cancer on MRI Scans
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials
Drugs
Molecular Dx
Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials
Inside Precision Medicine Staff Writer
-
June 21, 2017
0
Molecular Dx
Thermo Fisher to Develop NGS-based CDx for Agios’ Cancer Candidate
Inside Precision Medicine Staff Writer
-
May 18, 2017
0
News & Features
New CRISPR Technique to Activate Silent Gene Clusters Could Yield New Drugs
Inside Precision Medicine Staff Writer
-
April 11, 2017
0
Molecular Dx
Myriad to Develop CDx for BeiGene’s PARP Inhibitor BGB-290
Inside Precision Medicine Staff Writer
-
April 6, 2017
0
Molecular Dx
Loxo Oncology, Ventana in CDx Development Collaboration for Cancer Candidate Larotrectinib
Inside Precision Medicine Staff Writer
-
March 20, 2017
0
Informatics
In Silico Insights: Harnessing Bioinformatics to Find New Breast Cancer Drug Combinations
Diana Kwon
-
February 7, 2017
0
Molecular Dx
Strata Oncology to Offer Patient ID and Enrollment for Epizyme Trial of NHL Candidate
Inside Precision Medicine Staff Writer
-
February 6, 2017
0
Molecular Dx
GenomeDx Tests, Database to Help Astellas Identify Patients for Prostate Cancer Drug Xtandi
Inside Precision Medicine Staff Writer
-
February 1, 2017
0
Molecular Dx
Researchers Link Effect of Cancer Drug With Alzheimer’s-Protecting Mutation
Inside Precision Medicine Staff Writer
-
January 24, 2017
0
Molecular Dx
New Sequencing Technique for Cisplatin Damaged DNA Unveiled
Inside Precision Medicine Staff Writer
-
October 24, 2016
0
1
...
56
57
58
Page 57 of 58
Related Content
Sequencing Benefits Even Low-Income Rare Disease Patients, iHope Study Shows
Druggable Target for Anti–PD-1 Immunotherapy Induced Neurotoxicity Identified
Doxorubicin Loaded Algae-Based Microrobots Improved Lung Cancer Survival in Mice
Voices of Black Women Program Takes on Cancer Disparity
Inside Precision Medicine
![Companies will use clonSEQ Assay for measuring minimal residual disease in multiple myeloma patients who have been treated with Darzalex. [iStock/©dmbaker]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1138.jpeg "Janssen Biotech to Use Adaptive’s clonoSEQ Assay in Darzalex Myeloma Trials")
